ResearcherKyung Hee UniversityActive in the last 2 years
Yu‐Sun Lee
Matched on ORCID iD 0000-0001-8358-984X; OpenAlex author ID A5031294242. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 6
- Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mous… Co-author DOI 10.1080/02656736.2026.2716349↗
- ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. Co-author DOI 10.1016/j.bbadis.2024.167625↗
- New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.jproteome.3c00632↗
- Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment. First author DOI 10.1016/j.jconrel.2023.03.048↗
- Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Sam… Co-author DOI 10.3389/fonc.2019.00875↗
- Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse mo… Co-author DOI 10.1016/j.canlet.2013.10.028↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yun‐Hee Kim · 4 shared papers, 2019–2025 · strength 0.63
- Paper New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.jproteome.3c00632↗
- Paper ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. DOI 10.1016/j.bbadis.2024.167625↗
- Paper Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment. DOI 10.1016/j.jconrel.2023.03.048↗
- Sang Myung Woo · 4 shared papers, 2019–2025 · strength 0.63
- Paper New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.jproteome.3c00632↗
- Paper ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. DOI 10.1016/j.bbadis.2024.167625↗
- Paper Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment. DOI 10.1016/j.jconrel.2023.03.048↗
- Hye Won Shon · 2 shared papers, 2025–2026 · strength 0.49
- Sun‐Young Kong · 3 shared papers, 2019–2025 · strength 0.48
- Paper New Function Annotation of PROSER2 in Pancreatic Ductal Adenocarcinoma. DOI 10.1021/acs.jproteome.3c00632↗
- Paper ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. DOI 10.1016/j.bbadis.2024.167625↗
- Paper Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Mo… DOI 10.3389/fonc.2019.00875↗
- Sun Il Choi · 2 shared papers, 2023–2026 · strength 0.44
- Paper Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in… DOI 10.1080/02656736.2026.2716349↗
- Paper Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment. DOI 10.1016/j.jconrel.2023.03.048↗
- Yun-Hee Kim · 1 shared paper, 2026 · strength 0.29
- Sang‐Jae Park · 2 shared papers, 2019–2024 · strength 0.28
- Woo Jin Lee · 2 shared papers, 2019–2025 · strength 0.28
- Woo Hyun Paik · 1 shared paper, 2025 · strength 0.20
- In Rae Cho · 1 shared paper, 2025 · strength 0.20
- Sung Jun Kim · 1 shared paper, 2025 · strength 0.20
- Jung Won Chun · 1 shared paper, 2025 · strength 0.20
- Sang Hyub Lee · 1 shared paper, 2025 · strength 0.20
- Ji Kon Ryu · 1 shared paper, 2025 · strength 0.20
- Yong‐Tae Kim · 1 shared paper, 2025 · strength 0.20
- In-Hoo Kim · 2 shared papers, 2014–2023 · strength 0.19
- Paper Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment. DOI 10.1016/j.jconrel.2023.03.048↗
- Paper Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA r… DOI 10.1016/j.canlet.2013.10.028↗
- Mi Rim Lee · 1 shared paper, 2023 · strength 0.15
- Sung‐Sik Han · 1 shared paper, 2019 · strength 0.08
- Min Kyeong Kim · 1 shared paper, 2019 · strength 0.08
- Sung Yong Choi · 1 shared paper, 2019 · strength 0.08
- Kyong‐Ah Yoon · 1 shared paper, 2019 · strength 0.08
- Sang Seok Koh · 1 shared paper, 2014 · strength 0.03
- Yunhee Kim · 1 shared paper, 2014 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.